Equity analyst research on UK stocks from DirectorsTalk

Five UK Stocks to Watch in 2024
[shareaholic app="share_buttons" id_name="post_below_content"]

DirectorsTalk brings you professional opinions from leading equity research analysts on companies listed on the London Stock Exchange. This article contains a small selection of five stocks in the clean energy, financial services and telecommunications sectors. Equity analyst research across all sectors is available here. DirectorsTalk aims to help investors make more informed investment decisions.

Quadrise plc (LON:QED) produce transition fuels called MSAR® (pronounced ‘em-sar’) and bioMSAR™, which allow clients in the shipping, utilities and industrial sectors to reduce carbon emissions whilst also saving costs.

Arbuthnot Banking Group PLC (LON:ARBB), trading as Arbuthnot Latham, provides private and commercial banking products and services in the United Kingdom.

TEAM plc (LON:TEAM) is building a wealth, asset management and complementary financial services group. 

Cerillion plc (LON:CER) is a leading provider of billing, charging and customer management systems with more than 20 years’ experience delivering its solutions across a broad range of industries including the telecommunications, finance, utilities and transportation sectors.

Tern PLC (LON:TERN) is an AIM-listed provider of venture capital to exciting IoT innovators seeking scale and market share.

Share on:
Find more news, interviews, share price & company profile here for:

If our articles help you then why not add us as a preferred news source on Google.

Tern increases convertible loan note investment in Talking Medicines

Tern has received £270,000 of new unsecured convertible loan notes from Talking Medicines, increasing its total convertible loan note holding to approximately £0.79 million while retaining a 23.8% equity stake.

Tern Plc invests $280,000 in Device Authority convertible loan notes

Tern has invested $280,000 in new unsecured convertible loan notes issued by Device Authority, forming part of a wider funding round of up to $1.6 million from existing investors.

Surgical training technology moves closer to the centre of precision medicine

Fundamental XR is targeting a critical adoption gap in advanced healthcare by using immersive simulation to help surgical teams prepare for complex procedures with greater consistency and scale.

Unbrako secures funding to support expansion plans

Unbrako Group has secured an £8.6 million funding package to refinance existing facilities and support further expansion.

GLP-1 therapies move into a wider investor debate

GLP-1 therapies are moving beyond weight loss and diabetes, creating a wider investor discussion around behaviour, risk and market positioning.

Speed caps add a new dimension to telecoms monetisation

Mobile speed caps show how telecoms operators are turning network experience into a configurable commercial model, creating fresh relevance for flexible BSS and OSS platforms.

Search

Search